Author:
Hermesh Haggai,Aizenberg Dov,Weizman Abraham,Lapidot Margo,Mayor Catherina,Munitz Hanan
Abstract
The occurrence of neuroleptic malignant syndrome (NMS) was studied prospectively in two series of consecutive psychiatric in-patients (n = 223). The first group (n = 120) suffered from schizophrenia and was treated only with haloperidol. The second group (n=103) was treated with diverse neuroleptics. All patients were on a single antipsychotic agent with no anticholinergic drug as prophylaxis. The incidence of full NMS per admission and first neuroleptic exposure was 5/223 (2.2%). Patients with bipolar affective disorder and those treated with injections were significantly over-represented in the NMS group.
Publisher
Royal College of Psychiatrists
Subject
Psychiatry and Mental health
Reference13 articles.
1. Un neuroleptique majeur non phenothiazinque et non reserpinque, l'haloperidol, dans le traitement des psychoses;Delay;Annates Medico Psychologique,1960
2. Severe and Life-Threatening Adverse Reactions to Psychotropic Drugs
3. Frequency and presentation of NMS: a prospective study;Keck;American Journal of Psychiatry,1987
4. Neuroleptic malignant syndrome;Levenson;American Journal of Psychiatry,1985
5. Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital;Pope;American Journal of Psychiatry,1986
Cited by
63 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献